For further details see:
Hot Stocks: CAT, CMCSA slip despite Street-beating earnings; QCOM, MRK riseFor further details see:
Hot Stocks: CAT, CMCSA slip despite Street-beating earnings; QCOM, MRK riseMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the first patient has been dosed in the IDeate-Lung02 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab deruxtecan (I-DXd) in patients with...
2024-07-31 11:00:10 ET Geoff Meacham from Bank of America Securities issued a price target of $145.00 for MRK on 2024-07-31 09:50:00. The adjusted price target was set to $145.00. At the time of the announcement, MRK was trading at $115.21. The overall price target conse...
2024-07-30 14:15:13 ET Image source: The Motley Fool. Merck (NYSE: MRK) Q2 2024 Earnings Call Jul 30, 2024 , 9:00 a.m. ET Operator Continue reading For further details see: Merck (MRK) Q2 2024 Earnings Call Transcript